A staff team including 6 board-certified thoracic surgeons provides surgical treatment for lung cancer and other neoplastic diseases of the lung, mediastinum, pleura, and chest wall, collaboratively with pulmonologists and radiologists.
In 2014, we started lung transplantation program for patients suffering from end-stage diffuse lung diseases refractory to conventional medical therapies.
We also treat non-neoplastic diseases of the chest, including pulmonary inflammatory disorders, pneumothorax, pulmonary emphysema, funnel chest, hyperhidrosis, and myasthenia gravis.

• Extended resections and reconstructive surgeries for advanced lung and mediastinal malignancies are also performed in our department.
• Thoracoscopic diagnosis for indeterminate pulmonary or mediastinal diseases (VAL-MAP)
• Lung transplant: Lung transplantation from living and brain-dead donors for severe diffuse pulmonary disease has been performed since FY2015. 29 cases underwent lung transplantation in 2020.
• Robot-assisted surgery: Robot-assisted surgery using “da Vinci” is performed for lung cancer and mediastinal tumors with the same degree of sensitivity and accuracy as thoracoscopic surgery.

Primary lung cancer, pulmonary metastasis, other lung tumors, thymoma, other mediastinal tumors, pleural mesothelioma, chest wall tumor, spontaneous pneumothorax, pulmonary mycosis, pulmonary atypical mycobacteriosis, pulmonary emphysema, funnel chest, hyperhidrosis, and thoracoscopic pulmonary biopsy for pulmonary abnormal shadow and diffuse pulmonary diseases

• Complete thoracoscopic lobectomy for early-stage lung cancer
• Lung transplantation
• Virtual assisted lung mapping (VAL-MAP) for detecting intrapulmonary small lesion

(2014)